{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:48:37Z","timestamp":1787168917476,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,18]]},"DOI":"10.7759\/cureus.67138","type":"journal-article","created":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T18:30:37Z","timestamp":1724005837000},"source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Challenges in a Case of Immune-Mediated Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency"],"prefix":"10.7759","author":[{"given":"Karel","family":"Escoto-Pineda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Alas-Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Javier","family":"Pav\u00f3n-Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.03.040","article-title":"Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura","volume":"158","author":"Mingot Castellano ME","year":"2022","unstructured":"Mingot Castellano ME, Pascual Izquierdo C, Gonz\u00e1lez A, et al.. Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura. Med Clin (Barc). 2022, 158:630.e1-630.e14. 10.1016\/j.medcli.2021.03.040","journal-title":"Med Clin (Barc)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24221","article-title":"Thrombotic thrombocytopenic purpura: a rare cause of severe acute kidney injury","volume":"14","author":"Najar H","year":"2022","unstructured":"Najar H, Tuider L, Kukkar V, Quasem M. Thrombotic thrombocytopenic purpura: a rare cause of severe acute kidney injury. Cureus. 2022, 14:e24221. 10.7759\/cureus.24221","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11041103","article-title":"Severe thrombotic thrombocytopenic purpura (TTP) with organ failure in critically ill patients","volume":"11","author":"Fodil S","year":"2022","unstructured":"Fodil S, Zafrani L. Severe thrombotic thrombocytopenic purpura (TTP) with organ failure in critically ill patients. J Clin Med. 2022, 11:10.3390\/jcm11041103","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/08850666231171907","article-title":"Current intensive care management of thrombotic thrombocytopenic purpura: a case report and updated literature review","volume":"38","author":"Okoli S","year":"2023","unstructured":"Okoli S, Jenkins KA, Bojanowski CM. Current intensive care management of thrombotic thrombocytopenic purpura: a case report and updated literature review. J Intensive Care Med. 2023, 38:592-7. 10.1177\/08850666231171907","journal-title":"J Intensive Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2019.1611423","article-title":"An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura","volume":"12","author":"Joly BS","year":"2019","unstructured":"Joly BS, Coppo P, Veyradier A. An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert Rev Hematol. 2019, 12:383-95. 10.1080\/17474086.2019.1611423","journal-title":"Expert Rev Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13658","article-title":"Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative","volume":"171","author":"Bendapudi PK","year":"2015","unstructured":"Bendapudi PK, Li A, Hamdan A, et al.. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative. Br J Haematol. 2015, 171:836-44. 10.1111\/bjh.13658","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.26820\/recimundo\/4.(4).noviembre.2020.12-18","article-title":"Purpura trombocitop\u00e9nica tromb\u00f3tica: informe de caso cl\u00ednico (Article in Spanish)","volume":"4","author":"Nu\u00f1ez Matamoros G","year":"2020","unstructured":"Nu\u00f1ez Matamoros G, Delgado Carre\u00f1o J, Navas Serrano R, Ladines Castro WJ. Purpura trombocitop\u00e9nica tromb\u00f3tica: informe de caso cl\u00ednico (Article in Spanish). RECIMUNDO. 2020, 4:12-8. 10.26820\/recimundo\/4.(4).noviembre.2020.12-18","journal-title":"RECIMUNDO"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.60259","article-title":"Renal involvement in thrombotic thrombocytopenic purpura: is it time to challenge the old paradigm?","volume":"16","author":"Issa L","year":"2024","unstructured":"Issa L, Sandakly N, El Koubayati G, Khalil M, Haddad F. Renal involvement in thrombotic thrombocytopenic purpura: is it time to challenge the old paradigm?. Cureus. 2024, 16:e60259. 10.7759\/cureus.60259","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12826","article-title":"Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity","volume":"13","author":"Zafrani L","year":"2015","unstructured":"Zafrani L, Mariotte E, Darmon M, et al.. Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity. J Thromb Haemost. 2015, 13:380-9. 10.1111\/jth.12826","journal-title":"J Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19026","article-title":"A British Society for Haematology Guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies","volume":"203","author":"Scully M","year":"2023","unstructured":"Scully M, Rayment R, Clark A, et al.. A British Society for Haematology Guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies. Br J Haematol. 2023, 203:546-63. 10.1111\/bjh.19026","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully M","year":"2017","unstructured":"Scully M, Cataland S, Coppo P, et al.. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost. 2017, 15:312-22. 10.1111\/jth.13571","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2021.07.045","article-title":"Evaluation and management of thrombotic thrombocytopenic purpura in the emergency department","volume":"61","author":"Long B","year":"2021","unstructured":"Long B, Bridwell RE, Manchanda S, Gottlieb M. Evaluation and management of thrombotic thrombocytopenic purpura in the emergency department. J Emerg Med. 2021, 61:674-82. 10.1016\/j.jemermed.2021.07.045","journal-title":"J Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21760","article-title":"A modified PLASMIC score including the lactate dehydrogenase\/the upper limit of normal ratio more accurately identifies Chinese thrombotic thrombocytopenic purpura patients than the original PLASMIC score","volume":"35","author":"Zhao N","year":"2020","unstructured":"Zhao N, Zhou L, Hu X, et al.. A modified PLASMIC score including the lactate dehydrogenase\/the upper limit of normal ratio more accurately identifies Chinese thrombotic thrombocytopenic purpura patients than the original PLASMIC score. J Clin Apher. 2020, 35:79-85. 10.1002\/jca.21760","journal-title":"J Clin Apher"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","author":"Bendapudi PK","year":"2017","unstructured":"Bendapudi PK, Hurwitz S, Fry A, et al.. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. Published Online First. 2017, 10.1016\/S2352-3026(17)30026-1","journal-title":"Lancet Haematol. Published Online First"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02653.x","article-title":"The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange","volume":"50","author":"Bentley MJ","year":"2010","unstructured":"Bentley MJ, Lehman CM, Blaylock RC, Wilson AR, Rodgers GM. The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange. Transfusion. 2010, 50:1654-64. 10.1111\/j.1537-2995.2010.02653.x","journal-title":"Transfusion"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo P","year":"2010","unstructured":"Coppo P, Schwarzinger M, Buffet M, et al.. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One. 2010, 5:e10208. 10.1371\/journal.pone.0010208","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng XL","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR, et al.. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020, 18:2486-95. 10.1111\/jth.15006","journal-title":"J Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030536","article-title":"Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management","volume":"10","author":"Sukumar S","year":"2021","unstructured":"Sukumar S, L\u00e4mmle B, Cataland SR. Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management. J Clin Med. 2021, 10:10.3390\/jcm10030536","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/1076029618825309","article-title":"Comparison of the long-term remission of rituximab and conventional treatment for acquired thrombotic thrombocytopenic purpura: a systematic review and meta-analysis","volume":"25","author":"Owattanapanich W","year":"2019","unstructured":"Owattanapanich W, Wongprasert C, Rotchanapanya W, Owattanapanich N, Ruchutrakool T. Comparison of the long-term remission of rituximab and conventional treatment for acquired thrombotic thrombocytopenic purpura: a systematic review and meta-analysis. Clin Appl Thromb Hemost. 2019, 25:1076029618825309. 10.1177\/1076029618825309","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009150","article-title":"Redefining outcomes in immune TTP: an international working group consensus report","volume":"137","author":"Cuker A","year":"2021","unstructured":"Cuker A, Cataland SR, Coppo P, et al.. Redefining outcomes in immune TTP: an international working group consensus report. Blood. 2021, 137:1855-61. 10.1182\/blood.2020009150","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/264774-diagnostic-challenges-in-a-case-of-immune-mediated-thrombotic-thrombocytopenic-purpura-with-severe-adamts13-deficiency","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T18:30:40Z","timestamp":1724005840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/264774-diagnostic-challenges-in-a-case-of-immune-mediated-thrombotic-thrombocytopenic-purpura-with-severe-adamts13-deficiency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.67138","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,18]]}}}